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Katz and Gauchat (3) proposed that in cardiac tamponade, the
decrease in thoracic pressure that accompanies inspiration is blocked
from transmission to the right heart chambers by the elevated pericar-
dial pressure, thereby preventing the normal increase in systemic
venous return with inspiration. Subsequently, it was shown (4) that in
tamponade, most of the drop in thoracic pressure during inspiration is
transmitted to the heart and pericardium, and systemic venous return
is augmented by the normal mechanism despite raised pericardial
pressure. However, in constrictive pericarditis the heart is effectively
insulated from respiratory fluctuation of thoracic pressure. This insu-
lation prevents the development of an increased pressure gradient for
right heart filling during inspiration and, as emphasized by Klodas et
al. (2), diminishes the pressure gradient responsible for left ventricular
filling. Consequently, because total cardiac volume remains constant
throughout the respiratory cycle in constrictive pericarditis, right heart
volume increases. These data lead to the conclusion that in cardiac
tamponade, inspiratory increase in systemic venous return is a primary
event leading to diminution of left heart volume, whereas in constric-
tive pericarditis, diminished pulmonary venous return is the primary
event that leads to increased right heart volume. Had Katz and
Gauchat postulated their proposed mechanism for constriction instead
of tamponade, they would have been correct.
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Coronary Bypass Graft Surgery and
Patient Outcome
FitzGibbon and co-workers have previously made important contribu-
tions to our knowledge about the results of coronary bypass surgery
(CBS). In their recent study (1), they report the long-term results in
1,388 patients (all but 12 were men) who underwent CBS from 1969 to
1994. This study has important data, particularly with regard to the
long-term fate of vein grafts (graft disease and graft occlusion) up to
$15 years and especially about its effect on the need for reoperation
and on survival; the authors are to be congratulated in providing these
data.
They have also compared their results in men with our data (2) in
5,468 men operated on from 1969 to 1988 (and in the late cohort 1974
to 1988); however, they inadvertently did not cite our more detailed
study (3), based on gender, of the results of CBS in 6,927 men versus
1,979 women who underwent CBS from 1974 to 1991. They presented
very few baseline (preoperative) characteristics of their patients; for
example, the incidence of diabetes, previous myocardial infarction,
three-vessel coronary artery disease or left ventricular dysfunction is
not given. Therefore, we believe that one should be very careful about
a comparison with our study because of possible baseline differences in
the patients. They did provide data on the ages of the patients. Their
patients’ ages ranged from 27 to 79 years (mean 48.9 years), and they
emphasized the differences in the percent of patients #44 years old in
their and our study. A higher percentage of patients in their study were
#44 years old. However, an important age group is $55 years of age.
In their study, only 267 (19%) of 1,338 patients were $55 years old. In
our studies, of patients undergoing CBS from 1969 to 1988, the
average age of the patients was 60.7 years, and 88% were$55 years old
(2), and of male patients operated on from 1974 to 1991, the average
age was 61 years, and 73% were $55 years old (3). In the years 1984
to 1988 and 1989 to 1991, the frequency of male patients$65 years old
undergoing CBS was 45% and 52%, respectively (3). This is a very
important difference because the survival of patients is lower in those
who are older at the time of CBS. For example, the 10-year survival
rate of patients 46 to 54, 55 to 64, 65 to 74 and $75 years old at the
time of CBS was 86%, 75%, 60%, and 49%, respectively (3). However,
the relative survival (age and gender matched to the population) is very
favorable in the older patients, as they have shown (1) and which we
had previously documented (4). Analysis of survival in our study by
Cox regression model showed that the risks of mortality that were
statistically significant were older age, previous CBS, previous myocar-
dial infarction and diabetes, with a relative risk of 1.06, 1.57, 1.57 and
1.84, respectively (3). Besides an older age at time of performance of
CBS, many baseline preoperative characteristics have changed in
patients operated on from 1974 to 1991 (3). This is another reason why
one should be very careful about comparing data from the different
studies unless baseline preoperative patient characteristics are com-
pared and shown to be very similar.
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Reply
We appreciate Rahimtoola’s kind and generous remarks about our
work. The critique of the recent report (1), which he has admirably
summarized, is important and requires a response. His objection to
comparing incomparables is, of course, quite correct. However, we
listed comparative information mainly to assure the reader that the
survival results were not out of line with other long-term studies
because this was not the major thrust of the report.
Rahimtoola draws our attention to the more comprehensive (2) of
his recent reports (2,3), whose title does not do justice to its subject.
However, the survival data for 6,927 men (2) with coronary artery
bypass graft surgery (CABG) do not differ significantly from data for
the cohort of 5,648 men (3), with which we compared our results. We
reported a total 25-year experience. Our patients were insufficient in
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number and clinically distinct from the study by Rahimtoola et al.
(2,3), so that analysis of multiple baseline differences would not have
been helpful. We reported (4,5) elsewhere the insignificant preopera-
tive, perioperative, early and late survival differences between those
with and without angina at CABG. We did examine long-term survival
data for three age groups that differed significantly from those in the
study by Rahimtoola et al. For patients #39, 40 to 54 and $55 years
old, the 10-, 15- and 20-year survival rates were, respectively, 85%,
84% and 68%; 68%, 64% and 47%; and 55%, 46% and 30%. As we
noted, older patients caught up better with the predicted life spans of
their peers, but younger patients gained more years of life. Young
subjects in a predominantly military population have particularly
challenged us; we have reported our experience with CABG in subjects
#39 years old (6).
In our report (1), we stated that “Comparison with results reported
in other long-term studies is hindered by differences in patient age and
other disparities. For instance, only 6.3% of the patients in Rahimtoola
et al. were #44 years old, whereas 12% in our series were #39 years
old, with a wider discrepancy at later ages.” We probably spoiled the
exculpatory effect of this disclaimer by concluding “Nevertheless,
allowing for study differences but taking account of gender, our
survival rates appear superior”. Will Rahimtoola forgive this lapse
from scientific grace when he perceives that in summation of 25 years’
work, we claimed that our efforts “have yielded morbidity, mortality
and increased life expectancy results at least as good as those reported
by others.”?
GERALD M. FITZGIBBON, LRCP&S(IRELAND)
Cardio-Pulmonary Unit
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